MS News & Perspectives

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how telemedicine has been found to be effective during Italy’s Covid-19 lockdown.Multiple Sclerosis News Today’s columnist, Jessie Ace reads a column by Jenn Powell’s about how she is accepting that her illness makes her feel rare. =====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud =====================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a protein-targeting therapy found to lessen inflammation in preclinical studies.Multiple Sclerosis News Today’s columnist Jessie Ace reads a column by Jennifer Powell describes her experiences of traveling with Secondary Progressive Multiple sclerosis and the problems she’s faced because of her disability. =====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a European project which uses artificial intelligence to help improve patient care.Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “I Had a Stupid, Scary Spill, but It Could Have Been Much Worse”.=====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how the potential for stem cells to repair myelin is the focus of a team at the University Toronto.Multiple Sclerosis News Today’s columnist, Jessie Ace, reads an article by Jennifer Powell where she describes how she has found the importance of allowing her mind to work through grief and why you need to let go. =====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how NfL mirrors some life quality aspects felt by patients.Multiple Sclerosis News Today’s columnist Jessie Ace reads a column by Jennifer Powell where she describes what painsomnia is and how this affects her day-to-day life.=====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how age is found to be a main driver of MS disability.Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “The Disturbing Trend of Caregiver Abuse in the MS Community”.=====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses Innodem’s new way of diagnosing and tracking MS through eye movement.Multiple Sclerosis News Today's columnist Jessie Ace reads Jennifer Powell column where she discusses how she manages people’s expectations when they tell her about a possible ‘MS cure’. =====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud =====================================

Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how stem cell treatment is most effective for RRMS MS patients.Multiple Sclerosis News Today’s columnist Jessie Ace, reads Jennifer Powell column where she describes how her last 10 years have been affected by a diagnosis and how she chooses to see the positives. =====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the agenda for ACTRIMS 2021.Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Are You Having Trouble Paying for Your MS Medications?”.=====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud =====================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Jenn Powell sits with world-renowned neurologist, Tanuja Chitnis, MD, FAAN. Join the conversation as they discuss the longitudinal CLIMB study, pediatrics and MS, in addition to the cellular and psychosocial aspects of multiple sclerosis. Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/

Follow us on social media:
Instagram - http://www.instagram.com/msnewstoday/
Facebook - http://www.facebook.com/multiplesclerosisnewstoday
Twitter - http://twitter.com/msnewstoday

For more news on Multiple Sclerosis visit:
http://www.multiplesclerosisnewstoday.com/